Latest ebit for ISLEW: $-1.4M, below the sector sector average of $2.6T.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2022
Trailing 12 months ending Jun 30, 2022
As of the most recent data (June 2022), ISLEW shows a EBIT of $-1.4M. That compares with $67M in the prior-year period — down 102.0% year over year. That is below the sector sector average of $2.6T. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, ISLEW's EBIT is now $-1.4M (was $67M) — a 102.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Isleworth Healthcare Acquisition - Warrants (02/08/2027) is outperforming or lagging.
The its sector sector average EBIT is about $2.6T. Isleworth Healthcare Acquisition - Warrants (02/08/2027) is at $-1.4M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how ISLEW stacks up against individual peers as well.
Tracking ISLEW's ebit over time shows whether Isleworth Healthcare Acquisition - Warrants (02/08/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $-1.4M That compares with $67M in the prior-year period — down 102.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this ebit page, Stockcircle has Isleworth Healthcare Acquisition - Warrants (02/08/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-1.4M) with ownership activity and broader fundamentals.